Given the importance of NLPR3 in AAA pathogenesis and gasdermin D as an executive molecule in inflammasomes, we hypothesized that blocking gasdermin D activity inhibits experimental AAAs. The gene discussed is GSDMD; the disease is triple-A syndrome.